Skip to content
Search

Latest Stories

Survey: One-fifth of Britons seek health advice from pharmacists after symptom research

In a recent survey of 2,000 UK adults, 34 per cent preferred consulting pharmacists for health advice after researching symptoms, while for those surveyed specifically from Wales, this figure increased to 35 per cent, according to 2San -- a global supplier of healthcare products and solutions.

The survey said women had a higher tendency, with 39 per cent seeking their pharmacist's guidance compared to 29 per cent of men surveyed.


According to the survey findings, over one-fifth of people in the UK are turning to pharmacists instead of their primary care physician or doctor for guidance and advice with medical symptoms.

“With more than 38 million patients in the UK waiting more than two weeks for a GP appointment, it is unsurprising that 34 per cent of people surveyed asked a pharmacist for advice over their primary care physician/doctor in the last 12 months,” 2san said.

In Wales, over a third of people prefer their community pharmacist for support and advice, while those aged 65 and above still tend to consult their primary care physician.

Alarming trends 

One in six individuals was found to neglect listening to their bodies or addressing medical symptoms in recent months, leading to deteriorating conditions.  The survey highlighted this concerning trend amid an age of heightened awareness about the importance of early diagnosis and preventive care.

"The healthcare industry recognises the significant benefits of early diagnosis," said Neil Ashworth, non-executive chair at 2San. "It's worrisome to witness a trend in the past year where people disregard their symptoms and refrain from seeking help from medical professionals.”

The survey revealed that approximately three-quarters of people seeking alternative sources of information instead of consulting their GP. “About 55 per cent of individuals turn to online sources like Google and WebMD as their primary resource to research symptoms,” it added.

Among Generation Z, a quarter of 18-24-year-olds rely on social media for self-diagnosis, a trend noted as alarming in the 2San survey.

“Of equal concern is the growing reliance, especially among young people, on social media for medical self-diagnosis—a platform known for being unregulated and rife with misinformation,” Ashworth added.

Preferred choice: self-diagnostic tests

The survey found that rapid self-diagnostic tests are emerging as a valuable source of information, gaining popularity in the post-pandemic era. Over the past 12 months, 50 per cent of the surveyed population has utilised a rapid self-diagnostic test, with Generation Z taking the lead at 75 per cent among 18-24-year-olds.

One-fifth of consumers acknowledge its advantages, expressing a preference for these tests due to their convenience and the ability to perform them on their own schedule, the survey showed.

As we transition into a new era of healthcare, the testing method that became commonplace during the pandemic is now prompting those within and associated with the NHS and healthcare industries to explore its potential in other areas of diagnosis, 2San said.

Over 10 per cent of individuals aged 18-44 have bought a rapid self-diagnostic test to self-assess symptoms at home, the survey found. Londoners show the highest openness to these tests, with one in six purchasing them for home use.

Pandemic anxiety

While Covid-19 remains the most popular reason for using at-home tests (45 per cent of respondents), there is a growing trend in utilising tests for other diagnoses including urine infections (29 per cent), vitamin and mineral deficiencies (23 per cent), and bowel health (20 per cent).

Among respondents, over 50 per cent prioritised accuracy, ease of use, and cost when selecting a rapid self-diagnostic test. "Cost was particularly significant for the 35-44 age group, while those over 65 expressed concerns about tests lacking medical endorsement. In the current economic climate, sustainability was cited as an important factor by only 12 per cent of respondents."

"People are conscious of the NHS's challenges, causing them to hesitate in making appointments, possibly due to lengthy wait times or fearing they might be seen as time-wasters," Ashworth said. "Regardless of the reason, our goal is to instill confidence in people to approach healthcare professionals—starting with their local pharmacist for initial steps or their GP—to initiate the treatment process."

The recently released 2023 Community Barometer survey found that 62 per cent of respondents considered pharmacies the 'most essential service' among 16 options. Additionally, pharmacies ranked second (39 per cent) among the essential services with the most positive impact on the local area, following post offices (44 per cent).

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less